SCHEMBL30188574

SCHEMBL30188574

NC(=O)C1CN(c2ccsc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.37
HSD17B10 Q99714 3/20 0.37
GAA P10253 1/20 0.37
ALOX5 P09917 1/20 0.35
RORC P51449 1/20 0.34
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
POLB P06746 2/20 0.33
GLA P06280 1/20 0.33
NOTUM Q6P988 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
DAO P14920 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
NEK2 P51955 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28925994 0.84 NOTUM (0.45) POLBNOTUMLCKFYNDAO
SCHEMBL30147582 0.79 TSHR (0.40) SMN1; SMN2HSD17B10GAAGLANOTUM
SCHEMBL28926106 0.79 NAMPT (0.41) SMN1; SMN2HSD17B10GAAGLAKDM4E
SCHEMBL2297674 0.74 NOTUM (0.58) SMN1; SMN2RORCNOTUMKDM4EALDH1A1
SCHEMBL26422787 0.72 MAPT (0.32) POLB
SCHEMBL5053496 0.71 CHKA (0.44) HSD17B10RORCNOTUMMEN1KMT2A
SCHEMBL31411663 0.71 CHRM1 (0.35) ALDH1A1
SCHEMBL2283937 0.71 NOTUM (0.50) HSD17B10POLBNOTUMKDM4ENEK2
SCHEMBL31176447 0.69 GAA (0.47) SMN1; SMN2HSD17B10GAACES2CES1
SCHEMBL29280405 0.69 AKR1C3 (0.48) RORCPOLBNOTUMKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP claimed
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 EP disclosed